SELB Stock: Selecta Biosciences, Inc. Stock Price, Analysis & Insights

Get live SELB stock price $0.88, comprehensive Selecta Biosciences, Inc. stock analysis, charts, news, and expert forecast. Real-time SELB stock data and investment insights.

Quick links:Financial Metrics•Earnings•Analyst Forecasts•Financials•Technicals

0.88

8.00%Today

SELB • Selecta Biosciences, Inc. • NASDAQ Global Market • Healthcare

Market Cap

135.20M

Volume

2.76M

52W High

1.99

52W Low

0.79

Loading chart data...

Investment Score

Annual (latest period)

Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

View full dashboardUnlock quarterlyFaster signals · Pro+

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical firm dedicated to the research and development of innovative nanoparticle immunomodulatory medications aimed at treating and preventing various human ailments. The company's most advance...

Contact Information

Website: https://selectabio.com
Address: 65 Grove Street
Country: US

Investment Analysis & Business Insights

Healthcare

Biotechnology

Investment Highlights

✓ Strong presence in the Healthcare sector with established market position

Important Investment Considerations

⚠All investments carry risk, including potential loss of principal for Selecta Biosciences, Inc. shareholders
⚠Market volatility can significantly impact stock price, especially for smaller companies
⚠Sector-specific risks in Healthcare may affect company performance
⚠Past performance does not guarantee future results for Selecta Biosciences, Inc.
⚠Investors should consider how Selecta Biosciences, Inc. fits within their overall portfolio allocation
⚠Valuation metrics suggest potential, but require fundamental analysis

Market Cap

135.20M

P/E Ratio (TTM)

-3.04

Beta

0.83

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

Related Stocks

Compare SELB with peer companies:

aTyr Pharma, Inc. (ATYR)

Price: $0.46
Market cap: 45.37M

Cyteir Therapeutics, Inc. (CYT)

Price: $3.02
Market cap: 108.71M

Decibel Therapeutics, Inc. (DBTX)

Price: $4.91
Market cap: 123.37M

F-star Therapeutics, Inc. (FSTX)

Price: $7.12
Market cap: 156.51M

Kinnate Biopharma Inc. (KNTE)

Price: $2.65
Market cap: 124.99M

NGM Biopharmaceuticals, Inc. (NGM)

Price: $1.54
Market cap: 128.53M

Opiant Pharmaceuticals, Inc. (OPNT)

Price: $20.65
Market cap: 108.80M

Pardes Biosciences, Inc. (PRDS)

Price: $2.18
Market cap: 135.19M

Paratek Pharmaceuticals, Inc. (PRTK)

Price: $2.23
Market cap: 127.83M

Sesen Bio, Inc. (SESN)

Price: $0.63
Market cap: 127.96M

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.